The Importance of Phase Angle in Hemodialysis Patients

Oct 13, 2025 by pynkocean.com 100 views

The Influence Between the Combination of Hemodialysis/Hemoperfusion with Life Expectations (Phase Angle) in Hemodialysis Patients

Introduction

Chronic Kidney Disease (CKD) is a serious condition that requires kidney replacement therapy such as hemodialysis. Despite receiving dialysis therapy, the morbidity and mortality rates of CKD patients are still high. This is related to the accumulation of untreated uremic toxins during the hemodialysis process, especially large, medium, and small toxins. Combination of hemodialysis/hemoperfusion (HD/HP) offers a solution to overcome this problem. Hemoperfusion is an effective additional method in cleaning large, medium, and small uremic toxins.

The Importance of Phase Angle in Hemodialysis Patients

Phase Angle is a parameter that can be used to assess the quality of life of hemodialysis patients. This parameter shows the overall nutritional and health status. The higher the phase angle value, the better the quality of life of the patient. Therefore, it is essential to examine the effect of the combination of HD/HP on life expectancy, which is measured through phase angle, in regular hemodialysis patients.

Research Methods

This study uses a prospective cohort design of 20 regular hemodialysis patients conducted during the period December 2013 to March 2014. The data collected includes anamnesis, height measurement, weight, body mass index, and assessment of angle phase with Bioelectrical Impedance Analysis (BIA).

Research Results

Of the 19 subjects studied, an increase in the value of the angle after a combination of HD/HP, but this increase was not statistically significant (5.25 ± 1,980 vs 5.63 ± 2,420). That is, the combination of HD/HP does not show a significant effect on the increase in angle phase.

The study also found that the phase angle after the combination of HD/HP was not influenced by the sex and etiology of the final stage of kidney disease.

Conclusion

This study shows that there is no significant difference to the value of the angle after the HD/HP combination. Although the combination of HD/HP does not show a significant effect on the angle phase, keep in mind that this research has limitations, namely the relatively small number of samples. Further research needs to be done with a larger number of samples and longer observation time to obtain stronger and more accurate data.

Further Analysis

The results of this study need to be further examined by considering other factors that may affect the angle phase in hemodialysis patients, such as nutritional status, inflammation, and comorbid conditions.

Recommendation

It is essential to improve the quality of life of hemodialysis patients by optimizing dialysis therapy and providing adequate health education.
Further research with a larger number of samples and longer observation time is needed to examine the effect of the combination of HD/HP on phase angle.
It is essential to explore other strategies to increase the phase of the angle and the quality of life of hemodialysis patients.

The Future of Hemodialysis Therapy

In conclusion, the combination of HD/HP is a promising therapy strategy, but further research needs to be done to understand its effect on the life expectancy of hemodialysis patients. In addition, it is essential to improve the quality of life of hemodialysis patients by optimizing dialysis therapy and providing adequate health education.

Limitations of the Study

This study has several limitations, including the relatively small number of samples and the short observation time. Therefore, further research is needed to confirm the findings of this study and to explore the effect of the combination of HD/HP on phase angle in a larger and more diverse population.

Implications for Clinical Practice

The results of this study have implications for clinical practice, particularly in the management of hemodialysis patients. Healthcare providers should consider the combination of HD/HP as a potential therapy strategy to improve the quality of life of hemodialysis patients. However, further research is needed to confirm the effectiveness of this therapy strategy.

Future Directions for Research

Future research should focus on exploring the effect of the combination of HD/HP on phase angle in a larger and more diverse population. Additionally, researchers should investigate other factors that may affect the angle phase in hemodialysis patients, such as nutritional status, inflammation, and comorbid conditions.

Conclusion

In conclusion, this study provides new insights into the effect of the combination of HD/HP on life expectancy, which is measured through phase angle, in regular hemodialysis patients. Although the combination of HD/HP does not show a significant effect on the angle phase, further research is needed to confirm the findings of this study and to explore the effect of this therapy strategy on a larger and more diverse population.
Frequently Asked Questions (FAQs) About the Combination of Hemodialysis/Hemoperfusion and Life Expectancy in Hemodialysis Patients

Q: What is the purpose of combining hemodialysis and hemoperfusion?

A: The combination of hemodialysis and hemoperfusion is a therapy strategy that aims to remove large, medium, and small uremic toxins from the body, which can improve the quality of life of hemodialysis patients.

Q: What is phase angle, and why is it important in hemodialysis patients?

A: Phase angle is a parameter that can be used to assess the quality of life of hemodialysis patients. It shows the overall nutritional and health status of the patient. The higher the phase angle value, the better the quality of life of the patient.

Q: What are the benefits of combining hemodialysis and hemoperfusion?

A: The combination of hemodialysis and hemoperfusion can help to remove large, medium, and small uremic toxins from the body, which can improve the quality of life of hemodialysis patients. It can also help to reduce the accumulation of toxins in the body, which can lead to complications such as cardiovascular disease and kidney failure.

Q: What are the limitations of the study?

A: The study has several limitations, including the relatively small number of samples and the short observation time. Therefore, further research is needed to confirm the findings of this study and to explore the effect of the combination of hemodialysis and hemoperfusion on phase angle in a larger and more diverse population.

Q: What are the implications of the study for clinical practice?

A: The results of the study have implications for clinical practice, particularly in the management of hemodialysis patients. Healthcare providers should consider the combination of hemodialysis and hemoperfusion as a potential therapy strategy to improve the quality of life of hemodialysis patients.

Q: What are the future directions for research?

A: Future research should focus on exploring the effect of the combination of hemodialysis and hemoperfusion on phase angle in a larger and more diverse population. Additionally, researchers should investigate other factors that may affect the angle phase in hemodialysis patients, such as nutritional status, inflammation, and comorbid conditions.

Q: Can the combination of hemodialysis and hemoperfusion improve the quality of life of hemodialysis patients?

A: Yes, the combination of hemodialysis and hemoperfusion can help to improve the quality of life of hemodialysis patients by removing large, medium, and small uremic toxins from the body. However, further research is needed to confirm the effectiveness of this therapy strategy.

Q: What are the potential risks and complications of the combination of hemodialysis and hemoperfusion?

A: The combination of hemodialysis and hemoperfusion is generally considered safe, but it can cause complications such as bleeding, infection, and allergic reactions. Therefore, patients should be carefully monitored during and after the procedure.

Q: How can healthcare providers improve the quality of life of hemodialysis patients?

A: Healthcare providers can improve the quality of life of hemodialysis patients by optimizing dialysis therapy, providing adequate health education, and exploring other therapy strategies such as the combination of hemodialysis and hemoperfusion.

Q: What are the next steps for research on the combination of hemodialysis and hemoperfusion?

A: The next steps for research on the combination of hemodialysis and hemoperfusion include conducting larger and more diverse studies to confirm the effectiveness of this therapy strategy, investigating other factors that may affect the angle phase in hemodialysis patients, and exploring other therapy strategies to improve the quality of life of hemodialysis patients.